Evolus
(NASDAQ) EOLS
Evolus Financials at a Glance
Market Cap
$457.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$301.79M
Net Income (TTM)
-$43.42M
EPS (TTM)
-$0.67
P/E Ratio
-10.35
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$6.93
Volume
30,764
Open
$7.04
Price
$6.93
Volume
30,764
Open
$7.04
Previous Close
$6.93
Daily Range
$6.83 - $7.04
52-Week Range
$3.86 - $10.20
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$6.93
Volume
30,764
Open
$7.04
Previous Close
$6.93
Daily Range
$6.83 - $7.04
52-Week Range
$3.86 - $10.20
Estimated Earnings Date
Aug 4, 2026
EOLS News
Why Evolus Stock Soared Today
Why Evolus Shares Jumped This Week
EOLS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evolus
Industry
Pharmaceuticals
Sector
Health CareEmployees
334
CEO
David Moatazedi, MBA
Website
www.evolus.comHeadquarters
Newport Beach, CA 92660, US
EOLS Financials
Key Financial Metrics (TTM)
Gross Margin
65.55%
Operating Margin
-9.56%
Net Income Margin
-14.39%
Return on Equity
174.92%
Return on Capital
-28.51%
Return on Assets
-19.68%
Earnings Yield
-9.66%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$457.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
65.85M
Volume
30.76K
Avg. Volume
820.62K
Financials (TTM)
Gross Profit
$197.81M
Operating Income
-$28.86M
EBITDA
-$14.03M
Operating Cash Flow
-$36.59M
Capital Expenditure
-$7.01M
Free Cash Flow
-$43.59M
Cash & ST Invst.
$49.79M
Total Debt
$164.90M
Evolus Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$73.14M
+6.7%
Gross Profit
$47.36M
+1.5%
Gross Margin
64.75%
N/A
Market Cap
$457.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.23M
N/A
Employees
372
N/A
Net Income
-$10.67M
+43.5%
EBITDA
-$3.75M
+70.2%
Quarterly Fundamentals
Total Cash
$49.79M
-26.7%
Total Debt
$164.90M
+26.7%
Accounts Receivable
$52.22M
+10.0%
Inventory
$24.80M
+147.3%
Long Term Debt
$162.35M
+26.6%
Short Term Debt
$2.55M
+29.7%
Return on Assets
-19.68%
N/A
Return on Invested Capital
-18.91%
N/A
Free Cash Flow
-$10.37M
+40.7%
Operating Cash Flow
-$9.95M
+36.3%